Titan Laboratories Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.97 Cr
as on 16-11-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 79.60 Cr
as on 16-11-2024
- Satisfied Charges ₹ 11.43 Cr
as on 16-11-2024
- Revenue 25.49%
(FY 2023)
- Profit 94.34%
(FY 2023)
- Ebitda 55.50%
(FY 2023)
- Net Worth 41.80%
(FY 2023)
- Total Assets 18.09%
(FY 2023)
About Titan Laboratories
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.97 Cr.
The company currently has active open charges totaling ₹79.60 Cr. The company has closed loans amounting to ₹11.43 Cr, as per Ministry of Corporate Affairs (MCA) records.
Piyush Shah and Deepak Shah serve as directors at the Company.
- CIN/LLPIN
U24100MH2004PTC146928
- Company No.
146928
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Titan Laboratories?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Piyush Shah  | Managing Director | 14-Jun-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Deepak Shah | Whole-Time Director | 01-Apr-2008 | Current |
Financial Performance of Titan Laboratories.
Titan Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 25.49% increase. The company also saw a substantial improvement in profitability, with a 94.34% increase in profit. The company's net worth Soared by an impressive increase of 41.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Titan Laboratories?
In 2023, Titan Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Titan Pharma (India ) Private LimitedActive 23 years 3 monthsPiyush Shah and Deepak Shah are mutual person
- Titan Pharmaplus Private LimitedActive 2 years 9 months
Piyush Shah and Deepak Shah are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Jan 2023 | ₹2.00 M | Open |
Others Creation Date: 06 Jan 2023 | ₹20.00 Cr | Open |
Others Creation Date: 16 Jan 2020 | ₹7.20 Cr | Open |
How Many Employees Work at Titan Laboratories?
Titan Laboratories has a workforce of 305 employees as of Sep 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Titan Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Titan Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
